Human breast tumors have recently been classified by Santagata et al. [6] according to vitamin D, androgen, and estrogen hormone receptor expression, suggesting that combining VDR agonists (i.e. 1, 25D or analogues) with standard chemotherapy treatment could inhibit proliferation more effectively than chemotherapy alone [6]. The gene discussed is VDR; the disease is breast neoplasm.